EDGAR Filing Documents for 0001399529-20-000032

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001399529-20-000032

Filing Date

2020-04-22

Accepted

2020-04-22 16:09:25

Documents

Effectiveness Date

2020-04-22

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	drna-2020xdefa14a.htm	DEFA14A	31059
2		notice01.jpg	GRAPHIC	270407
3		notice02.jpg	GRAPHIC	377969
4		notice03.jpg	GRAPHIC	163832
5		notice04.jpg	GRAPHIC	54157
	Complete submission text file	0001399529-20-000032.txt		1225725

Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421

Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097

Dicerna Pharmaceuticals Inc (Filer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36281 | Film No.: 20808052
SIC: 2834 Pharmaceutical Preparations